Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes

被引：0
|
作者：
Venexia M. Walker
Marijana Vujkovic
Alice R. Carter
Neil M. Davies
Miriam S. Udler
Michael G. Levin
George Davey Smith
Benjamin F. Voight
Tom R. Gaunt
Scott M. Damrauer
机构：
[1] MRC University of Bristol Integrative Epidemiology Unit,Bristol Medical School: Population Health Sciences
[2] University of Bristol,Department of Surgery
[3] University of Pennsylvania Perelman School of Medicine,Department of Medicine
[4] University of Pennsylvania Perelman School of Medicine,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU
[5] Norwegian University of Science and Technology,Center for Genomic Medicine
[6] Massachusetts General Hospital,Division of Cardiovascular Medicine
[7] University of Pennsylvania Perelman School of Medicine,Department of Systems Pharmacology and Translational Therapeutics
[8] Corporal Michael Crescenz VA Medical Center,Department of Genetics
[9] University of Pennsylvania Perelman School of Medicine,Institute of Translational Medicine and Therapeutics
[10] University of Pennsylvania Perelman School of Medicine,undefined
[11] University of Pennsylvania Perelman School of Medicine,undefined
来源：
Diabetologia | 2022年 / 65卷
关键词：
Atherosclerotic cardiovascular disease; Coronary artery disease; Direct effect; Genome-wide association study; Indirect effect; Mediation; Mendelian randomisation; Peripheral artery disease; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：790 / 799
页数：9
相关论文
共 50 条
  • [41] Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden
    Katarina Steen Carlsson
    Mads Faurby
    Kristoffer Nilsson
    Michael Lyng Wolden
    Diabetes Therapy, 2023, 14 : 1357 - 1372
  • [42] ATHEROSCLEROTIC DISEASE LOCATION AND DISPARITIES IN THE CONTROL AND TREATMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES
    Gouni-Berthold, I.
    Bestehorn, K.
    Krone, W.
    Berthold, H. K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 33 - 33
  • [43] The Prevalence of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes in Jordan: The PACT-MEA Study
    Haddad, Jihad A.
    Annabi, Firas O. Abbas
    Abbasi, Hiba
    Abu Alsamen, Muneer A.
    Ammari, Fawaz L.
    Haddad, Fares H.
    Haddad, Suhair E.
    Jaradat, Mustafa
    Khassawneh, Adi
    Khatib, Nidal
    Magableh, Arabieh
    Al-Mousa, Eyas
    DIABETES THERAPY, 2025, : 899 - 913
  • [44] Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes
    Berthold, H. K.
    Bestehorn, K. P.
    Krone, W.
    Gouni-Berthold, I.
    DIABETIC MEDICINE, 2010, 27 (03) : 303 - 308
  • [45] Eligibility for Icosapent Ethyl in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: An Analysis of VERTIS CV
    Kim, Joseph M.
    Bhatt, Deepak L.
    Dagogo-Jack, Samuel
    Cherney, David
    Cosentino, Francesco
    McGuire, Darren K.
    Pratley, Richard E.
    Liu, Chih-Chin
    Cater, Nilo B.
    Frederich, Robert
    Mancuso, James P.
    Cannon, Christopher P.
    DIABETES, 2022, 71
  • [46] Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index
    Arsenault, Benoit J.
    Carpentier, Andre C.
    Poirier, Paul
    Despres, Jean-Pierre
    ATHEROSCLEROSIS, 2024, 394
  • [47] Atherosclerotic Disease Location Modifies Control and Treatment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes
    Gouni-Berthold, Ioanna
    Bestehorn, Kurt P.
    Krone, Wilhelm
    Berthold, Heiner K.
    CIRCULATION, 2009, 120 (18) : S547 - S547
  • [48] Bone Mineral Density Is Associated with Subclinical Atherosclerotic Cardiovascular Disease in Elderly Men with Type 2 Diabetes
    Chen, Yao
    Wang, Xingchun
    Ma, Bingwei
    Qu, Shen
    Wei, Dong
    DIABETES, 2020, 69
  • [49] Influence of the location and the extent of atherosclerotic vascular disease on new cardiovascular events in patients with type 2 diabetes
    Gorter, P. M.
    Visseren, F. L. J.
    Algra, A.
    van der Graaf, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 335 - 335
  • [50] Multifactorial Risk Control in Atherosclerotic Cardiovascular Disease Among Patients With Type 2 Diabetes Mellitus: Findings From the UK Biobank
    Fan, Wenjun
    Jiang, Luohua
    Malik, Shaista
    Wong, Nathan D.
    CIRCULATION, 2024, 149
12345